"Revenues from North America for FY15 at ₹64.7 billion, year-on-year growth of 17%.
Current year growth is shaped by scale-up of the injectable franchise and market share gains in select molecules"
Hopefully this may mean something
- Forums
- ASX - By Stock
- Dr. Reddy’s Q4 & FY15 Financial Results
"Revenues from North America for FY15 at ₹64.7 billion,...
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
NEWS
Is oil undervalued?
TSN (ASX) Chart |
Day chart unavailable